What is the issue size of the ARAGEN LIFE SCIENCES LIMITED IPO?

The total issue size is ₹800.00 crore.

ARAGEN LIFE SCIENCES LIMITED IPO — Dates, Price Band, Lot Size, Financials & Prospectus Analysis | Anvest

DRHP Filed — Dates AwaitedMAINBOARDOfficial SEBI Filing

ARAGEN LIFE SCIENCES LIMITED

Price Band

—

Total Issue Size

₹800 Cr

Bidding Window

—

Market Lot

—

Subscription

—

Issue Timeline & Lifecycle

DRHP Filed

1 Sept 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

DRHP Filed

1 Sept 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

AI Company Profile

AI Snapshot

ARAGEN LIFE SCIENCES LIMITED IPO

Founded:2020HQ:Plot 28A, IDA Nacharam, Hyderabad 500 076, Telangana, India

What Looks Strong

The offer document states no strength that could be verified.

What to Watch

The offer document states no risk factor that could be verified.

Fundamentals & Key Metrics

Period:FY26

Profitability & Returns

6 items

EBITDA Marginℹ

27.27%

Profit Marginℹ

8.47%

RoNWℹ

6.62%

ROCEℹ

14.47%

Basic EPSℹ

₹11.94

Book Valueℹ

₹102.83

Financial Health & Solvency

4 items

Debt/Equityℹ

0.00x

Net Worthℹ

₹2,231.24 Cr

Total Debtℹ

₹9.4 Cr

Operating Cash Flowℹ

₹375.86 Cr

Financials at a glance

Restated Consolidated

Statement: Income StatementPeriod: Restated Multi-Year (FY)

Shareholding, Ownership & Dilution

9 disclosed holders

Pre-Offer Shareholding Distribution

Breakdown of major disclosed shareholders prior to the issue

100.00% Pre-Issue

100%Pre-Offer

Davinder Singh Brar

22.02%

WSCPVIII (Singapore) Pte. Ltd.

21.20%

Madhubani Investments Private Limited

8.70%

Leo Investment Holdings Pte. Ltd.

7.21%

WSCPVIII EMP (Singapore) Pte. Ltd.

3.82%

Others

37.05%

Ownership Impact of the IPO

What is newly issued, what changes hands, and what stays put

The capital base is disclosed, but the offer is not priced and no complete offered-share count is available yet. A percentage would be speculative at this stage.

Disclosed Pre-Offer Shareholders Table

AI Summary

Filing-backed

Prospectus Research

Analyze business model, competitive strengths, use of issue proceeds, and disclosed risk factors with official page citations.

Issue intermediaries

Lead book managers

Axis Capital Limited, Citigroup Global Markets India Private Limited, Goldman Sachs (India) Securities Private Limited, JM Financial Limited

Registrar to the issue

KFin Technologies Limited

Listing venues

NSE,BSE

Listed Peer Valuation & Returns

Industry Avg P/E:68.89x

Swipe left / right to view all valuation metrics→

Company
Syngene International Ltd	49.03x	₹7.87	₹122.81	6.62%
Anthem Biosciences Ltd	77.58x	₹10.43	₹54.30	21.68%
Sai Life Sciences Ltd	80.04x	₹16.43	₹118.38	15.13%

Official Prospectus Filings

ARAGEN LIFE SCIENCES LIMITED - DRHP ARAGEN LIFE SCIENCES LIMITED - Draft Abridged Prospectus

Type: DRHP · Published: 2026-09-01

ARAGEN LIFE SCIENCES LIMITED

Issue Timeline & Lifecycle

What Looks Strong

What to Watch

Profitability & Returns

Financial Health & Solvency

Disclosed Pre-Offer Shareholders Table

AI Summary

Prospectus Research

Issue intermediaries

Listed Peer Valuation & Returns

Official Prospectus Filings

Frequently Asked Questions